Clinical Research Grants
Bristol-Myers Squibb has programs to support investigator-sponsored trials. Qualified scientists and physicians affiliated with academic medical centers; community health centers; cooperative groups; hospitals; physician networks; private practices; and universities are eligible to apply.
- Rationale. The trial must address a legitimate medical or scientific question affecting the use of a Bristol-Myers Squibb drug and not duplicate other planned or conducted research unless justified on a scientific or medical basis.
- Sponsor. The applicant (investigator, cooperative group, institution, network) must be qualified and capable of conducting the proposed study in compliance with the U.S. Food & Drug Administrations Good Clinical Practices. The sponsor must comply with all applicable legal and regulatory requirements and must not be the subject of any legal or regulatory restrictions or sanctions.
- Influence. Bristol-Myers Squibb maintains a strict policy of not exercising any influence or control over the design of any investigator-initiated clinical research trials financially supported by Bristol-Myers Squibb.
- Medical appropriateness of proposed research. The proposed research must be reasonably likely to produce results that could beneficially impact medical therapy for the condition being investigated.
- Scientific validity. The proposed study procedures must fulfill the stated objectives of the study.
- Ethical considerations. The study must be designed to meet ethical guidelines concerning human subjects in research (for interventional trials).
- Financial support. Funding requests must reasonably reflect the cost and effort involved and should not be used to defray normal operating expenses of the sponsor-investigator or institution that are not directly related to the supported research. An executed research agreement must be in place prior to any study commencing.
- All applicable regulatory requirements must be observed.
- Reporting study results. The results of the research will be collected and analyzed and a report of the study will be prepared and planned for potential publication in a peer-reviewed journal.
- Priority. We consider requests for clinical research trials in all clinical and therapeutic areas, and give priority to proposals in the following therapeutic areas: cardiovascular/metabolics, infectious diseases, neuroscience, cancer, immunology and virology.
All support for investigator-sponsored trials is awarded at the sole discretion of Bristol-Myers Squibb based on the criteria set forth above.
Before starting the submission process, please be sure to have the following information available.
1. Federal tax ID number for institution/organization (as applicable)
2. Organizational information (demographics)
3. Trial design and details
4. Valid e-mail address
5. Pharmacy or drug distribution contact information
6. Detailed budget
7. Study timeline
8. Statistical plan
9. Publication plan
A copy of the primary investigator’s current curriculum vitae must be submitted with the concept application.
Begin a new application >>
Return to a saved application >>